The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma.

Authors

Yafang Hu
Daniel Bobb
Jianping He
D. Ashley Hill, George Washington UniversityFollow
Jeffrey S. Dome, George Washington UniversityFollow

Document Type

Journal Article

Publication Date

1-2015

Journal

Cancer Biology and Therapy

Volume

16

Issue

6

Inclusive Pages

949-957

DOI

10.1080/15384047.2015.1040964

APA Citation

Hu, Y., Bobb, D., He, J., Hill, D. A., & Dome, J. S. (2015). The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma. Cancer Biology and Therapy, 16(6), 949-957. doi:10.1080/15384047.2015.1040964

Peer Reviewed

1